Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II; Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03179254
What this trial is testing

Type 2 Diabetes and Ambulatory Surgery Patients

Who this might be right for
Diabetes Type 2
University of Texas Southwestern Medical Center 160
Not applicableStudy completedNCT02505451
What this trial is testing

Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes

Who this might be right for
Diabetes-related Complications
University of Avignon 125
Not applicableStudy completedNCT06721429
What this trial is testing

Dual-Task Versus Combined Exercise Training in Older Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Bartın Unıversity 45
Not applicableStudy completedNCT05378295
What this trial is testing

Personalized Fiber and Insulin Sensitivity

Who this might be right for
Type 2 DiabetesInsulin Resistance
Maastricht University Medical Center 44
Early research (Phase 1)UnknownNCT01686139
What this trial is testing

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Who this might be right for
Type I Diabetes Mellitus With UlcerType II Diabetes Mellitus With Ulcer
Sheba Medical Center 12
Large-scale testing (Phase 3)Study completedNCT02100475
What this trial is testing

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 31
Not applicableStudy completedNCT01612520
What this trial is testing

Telecoaching of People With Type 2 Diabetes in Primary Care

Who this might be right for
Type 2 Diabetes MellitusTelenursing
KU Leuven 574
Not applicableStudy completedNCT05716724
What this trial is testing

O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 288
Not applicableStudy completedNCT02588859
What this trial is testing

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,200
Large-scale testing (Phase 3)Study completedNCT00251680
What this trial is testing

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

Who this might be right for
Type 2 Diabetes
Takeda 400
Not applicableStudy completedNCT03975556
What this trial is testing

Culturally-Adapted Diet for Puerto Rican Adults

Who this might be right for
Diabetes Mellitus, Type 2ObesityHypertension+4 more
Harvard School of Public Health (HSPH) 45
Not applicableStudy completedNCT04891575
What this trial is testing

Heart of the Family: A Cardiovascular Disease and Type 2 Diabetes Risk Reduction Intervention in High-Risk Rural Families

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
Gia Mudd 504
Post-approval studies (Phase 4)Study completedNCT01127269
What this trial is testing

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 178
Post-approval studies (Phase 4)Ended earlyNCT00766441
What this trial is testing

Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan

Who this might be right for
DiabetesHypoglycemia
University of Manchester 22
Not applicableStudy completedNCT04313829
What this trial is testing

Pharmacist Counseling on the Health-related Quality of Life of Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Universitas Padjadjaran 220
Large-scale testing (Phase 3)Study completedNCT05702073
What this trial is testing

To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 423
Testing effectiveness (Phase 2)Study completedNCT00025883
What this trial is testing

Leptin to Treat Lipodystrophy

Who this might be right for
Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 103
Not applicableLooking for participantsNCT06180837
What this trial is testing

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

Who this might be right for
Lifestyle FactorsOverweight and ObesityInsulin Sensitivity+6 more
University of Utah 70
Large-scale testing (Phase 3)Study completedNCT00396357
What this trial is testing

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 914
Large-scale testing (Phase 3)Looking for participantsNCT07743983
What this trial is testing

BGM0504 in Early T2DM With Obesity

Who this might be right for
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 372
Next Page